Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA
2.0.0-ballot - STU2 ballot United States of America flag

Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc-fda/ and changes regularly. See the Directory of published versions

: Drug Product Component Function Category Terminology - XML Representation

Active as of 2024-12-04

Raw xml | Download


<ValueSet xmlns="http://hl7.org/fhir">
  <id value="pqcmc-drug-product-component-function-category-terminology"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet pqcmc-drug-product-component-function-category-terminology</b></p><a name="pqcmc-drug-product-component-function-category-terminology"> </a><a name="hcpqcmc-drug-product-component-function-category-terminology"> </a><a name="pqcmc-drug-product-component-function-category-terminology-en-US"> </a><ul><li>Include these codes as defined in <a href="http://terminology.hl7.org/6.1.0/CodeSystem-v3-nciThesaurus.html"><code>http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>C82533</td><td>Active Ingredient</td></tr><tr><td>C2140</td><td>Adjuvant</td></tr><tr><td>C42637</td><td>Inactive Ingredient</td></tr></table></li></ul></div>
  </text>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
    <valueCode value="brr"/>
  </extension>
  <url
       value="http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-drug-product-component-function-category-terminology"/>
  <identifier>
    <system value="urn:ietf:rfc:3986"/>
    <value value="urn:oid:2.16.840.1.113883.4.642.40.36.48.10"/>
  </identifier>
  <version value="2.0.0-ballot"/>
  <name value="PqcmcDrugProductComponentFunctionCategoryTerminology"/>
  <title value="Drug Product Component Function Category Terminology"/>
  <status value="active"/>
  <experimental value="false"/>
  <date value="2024-12-04T20:50:29+00:00"/>
  <publisher value="HL7 International / Biomedical Research and Regulation"/>
  <contact>
    <name value="HL7 International / Biomedical Research and Regulation"/>
    <telecom>
      <system value="url"/>
      <value value="http://www.hl7.org/Special/committees/rcrim"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="brr@lists.HL7.org"/>
    </telecom>
  </contact>
  <description
               value="Terminology used to qualify the information pertaining to drug product component function categories in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents."/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="US"/>
      <display value="United States of America"/>
    </coding>
  </jurisdiction>
  <compose>
    <include>
      <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
      <concept>
        <code value="C82533"/>
        <display value="Active Ingredient"/>
      </concept>
      <concept>
        <code value="C2140"/>
        <display value="Adjuvant"/>
      </concept>
      <concept>
        <code value="C42637"/>
        <display value="Inactive Ingredient"/>
      </concept>
    </include>
  </compose>
</ValueSet>